An mHealth Intervention for Sedentary Behavior in Pregnant Women

August 1, 2024 updated by: Abbi Danielle Lane-Cordova, University of South Carolina

Pregnancy outcomes, such as excessive gestational weight gain and gestational diabetes, are linked to long and short-term maternal and child health. Interventions aimed at improving health behaviors, such as sedentary behavior (SB; i.e., any behavior in a seated or reclining position with low energy expenditure) are attractive because they are low-cost, can be disseminated in a wide variety of populations once pregnancy begins, and do not require drugs or prescriptions. Studies have linked SB to some pregnancy outcomes. To the investigators' knowledge, no studies have tested the efficacy of an intervention to reduce SB in pregnant women.

Over 90% of reproductive aged women own a smartphone with similar rates of ownership among black, white, and Hispanic/Latina women, and most adults carry smartphones while awake. Smartphones can monitor SB without additional equipment. Thus, smartphones offer a streamlined opportunity to intervene on SB. The purpose of the research is to evaluate the effectiveness and perception of an mHealth intervention aimed at changing SB in pregnant women. Investigators will survey providers regarding their SB opinions and counseling practices

Study Overview

Detailed Description

Investigators will recruit 28 pregnant women, 14 per arm, to participate in this pilot randomized, controlled study. Particiants will complete an in-person baseline study visit in early pregnancy (< week 16). The visit will occur in the Public Health Research Center, Discovery Building, or at a Prisma Health facility. Measurements at the in-person visit (~ 1 hr) include demographics, surveys regarding current and pre-pregnancy PA and SB, medical and pregnancy history, height, and weight. All participants will be given an activPAL(TM) (Glasgow, UK) at V1 to objectively measure SB for 1 week using gold-standard methodology. At the end of the 1-week run-in period (i.e., the week during which SB is objectively measured prior to randomization), participants will mail back the activPAL(TM) and be randomized to the mHealth SB intervention or control group for 12 weeks. SB will be objectively measured again using the activPAL(TM) from week 11-12 of the study. Surveys (Nausea and Vomiting of Pregnancy, Global Health Scales, inquiry about new diagnoses) will be administered remotely in week 5 and week 11. A recruitment opinion survey will be administered remotely in week 5 to inform future recruitment efforts. Surveys related to the intervention platform and perceived effectiveness will be administered remotely at week 12 to participants in the experimental group. Investigators will ask about new diagnoses or adverse events at week 5 and week 11. Investigators will link to participants' medical charts and abstract in-clinic body weight, the results of the third trimester glucose tolerance test, and any other pregnancy-related diagnoses. Investigators will survey Ob/Gyn clinicians (doctors, residents, and nurses) regarding their perceptions of SB during pregnancy.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Carolina
      • Columbia, South Carolina, United States, 29208
        • University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • currently <16 weeks pregnant with a single infant
  • at least 18 years old
  • normal weight, overweight, or obese body mass index prior to pregnancy
  • can read English at a 6th grade level
  • planning to continue pregnancy to term
  • owns smartphone and keeps it within arms reach during the day
  • willing to allow medical chart access for specific information during the current pregnancy
  • no absolute contraindications to exercise, i.e., a doctor has not told you not to exercise during pregnancy

Exclusion Criteria:

  • pre-pregnancy BMI <18.5 kg/m2
  • age <18 years
  • gestational age >16 weeks
  • multiple gestation
  • not planning to continue pregnancy to term
  • does not own a smartphone or keep smartphone within arms-reach during the day
  • pre-pregnancy type I or II diabetes
  • absolute contraindication to PA in pregnancy
  • not receiving prenatal care or not willing to allow access to medical chart
  • inability to read English at a 6th grade level.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sedentary behavior smartphone app
This arm will be assigned to download and use a smartphone app that prompts you to stand up when your smartphone detects 30 minutes of sitting.
This is a smartphone app that reminds you to stand up if you've been sitting for at least 30 minutes.
Active Comparator: Pregnancy smartphone app
This arm will download and use a commercially available pregnancy smartphone app that does not attempt to change activity behavior.
This is a commercially available general pregnancy smartphone app

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time spent in sedentary behavior
Time Frame: Week 11-12 of the intervention
Total minutes/day in sedentary behavior
Week 11-12 of the intervention
Weight gain
Time Frame: At delivery
Pregnancy weight gain
At delivery
Glucose tolerance test results
Time Frame: At clinic 1 ay visit glucose test
The blood glucose level at the third trimester glucose tolerance test
At clinic 1 ay visit glucose test

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pregnant patients' opinions of sedentary behavior
Time Frame: Baseline (before randomization)
Survey regarding feelings about sedentary behavior during pregnancy
Baseline (before randomization)
Pregnant patients' opinions of the NEAT!2 app
Time Frame: Week 12
Survey regarding feelings about the app for those assigned to the experimental group
Week 12
Providers' opinions and practices regarding sedentary behavior
Time Frame: until study is completed; about 1 year
MD/DO, RN, NP opinions and counseling practices related to sedentary behavior in pregnant patients
until study is completed; about 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Abbi D Lane-Cordova, PhD, University of South Carolina

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 17, 2021

Primary Completion (Actual)

July 20, 2023

Study Completion (Actual)

July 20, 2023

Study Registration Dates

First Submitted

May 14, 2021

First Submitted That Met QC Criteria

May 25, 2021

First Posted (Actual)

May 26, 2021

Study Record Updates

Last Update Posted (Actual)

August 6, 2024

Last Update Submitted That Met QC Criteria

August 1, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00110591

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We are willing to share deidentified data with other researchers. Researchers can contact us if they are interested.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on NEAT!2 sedentary behavior app

Subscribe